194 related articles for article (PubMed ID: 35438139)
1. Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease.
Ruscitti P; Ursini F; Berardicurti O; Masedu F; Bozzalla Cassione E; Naldi S; Di Cola I; Di Muzio C; De Stefano L; Di Nino E; Navarini L; Vomero M; Bugatti S; Valenti M; Mariani E; Iagnocco A; Montecucco C; Giacomelli R; Cipriani P
Rheumatology (Oxford); 2022 Dec; 62(1):321-329. PubMed ID: 35438139
[TBL] [Abstract][Full Text] [Related]
2. Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still's disease.
Hiyama T; Kurasawa K; Hasegawa A; Miyao T; Tanaka A; Arai S; Arima M; Maezawa R
Clin Exp Med; 2023 Nov; 23(7):3407-3416. PubMed ID: 36611087
[TBL] [Abstract][Full Text] [Related]
3. The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.
Ruscitti P; Berardicurti O; Di Cola I; Di Muzio C; Di Nino E; Giacomelli R; Cipriani P
Clin Exp Immunol; 2022 May; 208(1):95-102. PubMed ID: 35467709
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.
Jia J; Wang M; Ma Y; Meng J; Zhu D; Chen X; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Liu T; Zhou Z; Wang F; Chen L; Yi D; Xiao Y; Yang C; Teng J; Hu Q
BMC Med; 2023 Dec; 21(1):507. PubMed ID: 38124139
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study.
Di Cola I; Bruno F; Berardicurti O; Monti R; Conforti A; Di Sibio A; Pavlych V; Masciocchi C; Barile A; Cipriani P; Ruscitti P
Clin Rheumatol; 2021 Oct; 40(10):3971-3978. PubMed ID: 33855668
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.
Zhu D; Chen L; Meng J; Wang M; Ma Y; Chen X; Xiao Y; Yi D; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Zhou Z; Yang C; Teng J; Jia J; Hu Q
J Autoimmun; 2024 Apr; 144():103182. PubMed ID: 38460457
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
[TBL] [Abstract][Full Text] [Related]
11. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
[TBL] [Abstract][Full Text] [Related]
12. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
Yamabe T; Ohmura SI; Uehara K; Naniwa T
Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
[TBL] [Abstract][Full Text] [Related]
14. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
[TBL] [Abstract][Full Text] [Related]
15. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Circulating Natural Killer Cells and Their Interferon-γ Production in Active Adult-onset Still Disease.
Shimojima Y; Kishida D; Ueno KI; Ushiyama S; Ichikawa T; Sekijima Y
J Rheumatol; 2019 Oct; 46(10):1268-1276. PubMed ID: 30770498
[TBL] [Abstract][Full Text] [Related]
17. Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.
Ruscitti P; Iacono D; Ciccia F; Emmi G; Cipriani P; Grembiale RD; Perosa F; Emmi L; Triolo G; Giacomelli R; Valentini G
J Rheumatol; 2018 Jun; 45(6):864-872. PubMed ID: 29657144
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.
Chen PK; Lan JL; Huang PH; Hsu JL; Chang CK; Tien N; Lin HJ; Chen DY
Front Immunol; 2021; 12():719544. PubMed ID: 34367188
[TBL] [Abstract][Full Text] [Related]
19. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
Front Immunol; 2020; 11():603389. PubMed ID: 33552062
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.
Yang XP; Wang M; Li TF; Li W; Zhang L; Liu SY
Clin Exp Rheumatol; 2019; 37 Suppl 121(6):83-88. PubMed ID: 31287402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]